It is a pharma private limited company based in Sampatchak, Bihar, India, established in 2009.
2009 | Sampatchak, Bihar, India | ActiveLangelie Biologicals Pharma Private Limited, a active private limited company, was established on 10 August 2009 in Sampatchak, Bihar, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230BR2009PTC014749. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Alpana (Director), Madhumita Kumari (Director), Vivek Kumar Sinha (Director). Past directors included Alpana, Sanjay Kumar, Vivek Kumar Sinha. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Mig 8M/12, Bahadurpur Housing Colony, Kankarbagh, Sampatchak, Bihar, 800026.
U24230BR2009PTC014749
014749
10 August 2009
₹1.00 M
₹1.00 M
Roc Patna
Unlisted
Active
Explore comprehensive insights into Langelie Biologicals Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Alpana | Director | 25 May 2016 | Current |
| Madhumita Kumari | Director | 01 Nov 2019 | Current |
| Vivek Kumar Sinha | Director | 10 Aug 2009 | Current |
| Manish Kumar | Managing Director | 10 Aug 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 09 Apr 2016 | Past |
| Pramod Abcsdd | Managing Director | 14 Jul 2024 | Past |
| Pramod Abcsdd | Director | 14 Jul 2024 | Past |
| Pramod Abcsdd | Director | 27 Aug 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Langelie Biologicals Pharma Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 9.03% decrease. The company also saw a substantial improvement in profitability, with a 113.75% increase in profit. The company's net worth moved up by a moderate rise of 0.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Langelie Biologicals Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Langelie Biologicals Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Langelie Biologicals Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Langelie Biologicals Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Langelie Biologicals Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Langelie Biologicals Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Patna. was completed.
Progress on Madhumita Kumari was appointed as a Director was appointed as a Director on 01 Nov 2019 & has been associated with this company since 6 years 24 days . was documented.
The activity Alpana was appointed as a Director was appointed as a Director on 25 May 2016 & has been associated with this company since 9 years 6 months . was completed.
Progress on Vivek Kumar Sinha was appointed as a Director was appointed as a Director on 10 Aug 2009 & has been associated with this company since 16 years 3 months . was documented.
The activity Manish Kumar was appointed as a Managing Director was appointed as a Managing Director on 10 Aug 2009 & has been associated with this company since 16 years 3 months . was completed.
The CIN of Langelie Biologicals Pharma Private Limited is U24230BR2009PTC014749.
Langelie Biologicals Pharma Private Limited is headquartered at Mig 8M/12, Bahadurpur Housing Colony, Kankarbagh, Sampatchak, Bihar, 800026.
Langelie Biologicals Pharma Private Limited was incorporated on 10 August 2009.
The current directors of Langelie Biologicals Pharma Private Limited are
The primary industry of Langelie Biologicals Pharma Private Limited is Trade.
Langelie Biologicals Pharma Private Limited is unlisted.
The authorized capital of Langelie Biologicals Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Langelie Biologicals Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX